[Effect of cryodestruction and antioxidants on leukocyte hydrolase activity in patients with leukoplakia].
Mashkilleĭson
A L
AL
Suleimanova
G G
GG
Lagunov
A I
AI
D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003452:Cryosurgery; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006867:Hydrolases / Q000097:blood*; D007962:Leukocytes / Q000201:enzymology*; D007972:Leukoplakia, Oral / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014801:Vitamin A / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D004338:Drug Combinations; D014801:Vitamin A; D014810:Vitamin E; C048974:vitamin A, vitamin E drug combination; D006867:Hydrolases; D001205:Ascorbic Acid
Vliianie kriodestruktsii i antioksidantov na aktivnost' gidrolaz leĭkotsitov krovi bol'nykh leĭkoplakieĭ.